NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc.,(NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced a new agreement with Cato Research Ltd., a full-service contract research organization. Cato Research selected BioClinica’s clinical trial management system (CTMS) platform in its search for a best-in-class solution to better serve its growing worldwide client base.
